For example, many studies reported that inhibiting the GPR30 receptor on the cell surface of CAFs can inhibit the level of CXCL12 secreted by CAFs, reduce the recruitment of macrophages and M2-type polarization, thereby impairing the ability of prostate cancer cells to metastasize and invade [73]. This evidence concerns the gene CXCL12 and Familial prostate cancer.